3SBio Inc. (TRSBF)
OTCMKTS
· Delayed Price · Currency is USD
2.600
-0.300 (-10.34%)
May 28, 2025, 3:03 PM EDT
3SBio Employees
3SBio had 5,577 employees as of December 31, 2024. The number of employees increased by 166 or 3.07% compared to the previous year.
Employees
5,577
Change (1Y)
166
Growth (1Y)
3.07%
Revenue / Employee
$223,744
Profits / Employee
$51,350
Market Cap
5.60B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Tian'an Technology Group | 8 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 374 |
CytoDyn | 9 |
Northwest Biotherapeutics | 25 |
Silence Therapeutics | 116 |
American Oncology Network | 1,914 |
3SBio News
- 8 days ago - Pfizer Thinks Bigger With 3SBio Deal - Seeking Alpha
- 8 days ago - Pfizer Inks Up to $6B Deal to Market 3SBio's Cancer Drug Outside China - Investopedia
- 8 days ago - Pfizer strikes deal with China's 3SBio to license cancer drug - CNBC
- 9 days ago - Pfizer Secures Global Rights To China's 3SBio's Cancer Drug In $6 Billion Deal - Benzinga